A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

November 21, 2018

Study Completion Date

January 10, 2020

Conditions
Lung Diseases, Interstitial
Interventions
DRUG

Pirfenidone

Pirfenidone 267 mg capsules three times in a day.

DRUG

Placebo

Matching placebo capsules three times in a day.

Trial Locations (66)

7

Mater Misericordiae University hospital, Dublin

1070

ULB Hôpital Erasme, Brussels

1200

Cliniques Universitaires St-Luc, Brussels

2050

Royal Prince Alfred Hospital, Camperdown

2305

John Hunter Hospital; Respiratory Department; Respiratory Department, New Lambton Heights

2900

Gentofte Hospital, Lungemedicinsk Afdeling, Hellerup

3000

UZ Leuven Gasthuisberg, Leuven

3084

Respiratory Department, Heidelberg

3181

The Alfred Hospital, Prahan

4101

Lung Research Queensland, Nundah

4102

Princess Alexandra Hospital, Department of Respiratory and Sleep Medicine, Woolloongabba

4200

Hospital de Sao Joao; Servico de Pneumologia, Porto

5000

Royal Adelaide Hospital; Respiratory Clinical Trials Unit, Thoracic Medicine, Adelaide

Odense Universitetshospital, Lungemedicinsk Afdeling J, Odense C

6150

Fiona Stanley Hospital; Advanced Lung Disease Unit, Murdoch

8200

Aarhus Universitetshospital; Lungesygdomme, Forskning, Aarhus N

10043

A.O. Universitaria San Luigi Gonzaga di Orbassano; Ambulatorio per le Malattie Rare del Polmone, Orbassano (TO)

13125

Evang. Lungenklinik Berlin Klinik für Pneumologie, Berlin

20123

Ospedale San Giuseppe; U.O. di Pneumologia, Milan

28006

Hospital Universitario La Princesa; Servicio de Neumologia, Madrid

28040

Hospital Clínico San Carlos - Servicio de Neumologia, Madrid

28041

Hospital Universitario 12 de Octubre; Servicio de Neumologia, Madrid

35392

Klinik der Justus-Liebig-Universität; Innere Medizin, Giessen

39008

Hospital Universitario Marques de Valdecilla; Servicio de neumologia, Santander

47121

Ospedale Morgagni-Pierantoni; U.O. Pneumologia, Forlì

50134

Azienda Ospedaliero-Universitaria Careggi; SOD Pneumologia e Fisiopatologia Toracico Polmonare, Florence

58633

Nemocnice Jihlava, Jihlava

60100

A.O.U. Ospedali Riuniti Umberto I -G.M. Lancisi-G. Salesi Ancona; SOD Pneumologia, Torrette Di Ancona

69126

Thoraxklinik Heidelberg gGmbH, Heidelberg

81377

Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V, München

99437

Zentralklinik Bad Berka GmbH; Pneumologie, Bad Berka

3436212

Carmel Medical Center; Pulmonary Institute, Haifa

4428164

Meir Medical Center; Pulmonary Dept, Kfar Saba

4941492

Beilinson Medical Center; Pulmonary Inst., Petah Tikva

7610001

Kaplan Medical Center, Rehovot

8410101

Soroka; Pulmonary Clinic, Beersheba

9103102

Shaare Zedek Medical Center; Pulmonary Inst., Jerusalem

9112001

Hadassah Medical Center; Pulmonary Institute, Jerusalem

V6Z 1Y6

Pacifica Lung Research Center/St. Paul's Hospital, Vancouver

L8N4A6

St. Joseph's Healthcare Hamilton, Hamilton

639 00

Fakultni Nemocnice Brno-Bohunice; Klinika Tuberkulozy A Respiracnich Chorob, Brno

775 20

Fakultni nemocnice Olomouc; Pneumologicka klinika, Olomouc

128 08

Vseobecna fakultni nemocnice v Praze; I. klinika tuberkulozy a respiracnich nemoci, Prague

115 27

Sotiria Hospital for Diseases of the Chest, Academic Department of Pneumonology, Athens

124 62

"University General Hospital of Athens Attikon, B' University Pulmonary Clinic", Chaïdári

711 10

University General Hospital of Heraklio, Pulmonary Clinic, Heraklio

Unknown

St Vincents University Hospital, Dublin

80-214

Uniwersyteckie Centrum Kliniczne;Klinika Alergologii i Pneumonologii, Gdansk

90-153

Uniwersytecki Szpital Kliniczny Nr 1 im.N.Barlickiego Oddzial Kliniczny Pneumonologii i Alergologii, Lodz

01-138

Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc, Warsaw

3814-501

Hospital Infante D. Pedro; Servico de Pneumologia, Aveiro

3000-075

HUC; Servico de Pneumologia A, Coimbra

4434-502

CHVNG/E_Unidade 1; Servico de Pneumologia, Vila Nova de Gaia

08097

Hospital Universitari de Bellvitge ; Servicio de Neumologia, L'Hospitalet de Llobregat

B17 0NH

University Hospital Birmingham Queen Elizabeth Hospital, Birmingham

BS10-5NB

Southmead Hospital; Respiratory Department, Bristol

CB23 3RE

Papworth Hospital NHS Foundation Trust; Respiratory Department, Cambridge

EH16 4SA

Edinburgh Royal Infirmary; Respiratory Department, Edinburgh

EX2 5DW

Royal Devon and Exeter Hospital (Wonford), Exeter

LE3 9QP

Glenfield Hospital, Leicester

NW1 2BU

University College London Hospital; Respiratory Medicine, London

SW3 6NP

Royal Brompton Hospital; Respiratory Department, London

M23 9LT

Wythenshawe Hospital; North West Lung Research Centre, Manchester

S5 7AU

Northern General Hospital, Sheffield

SO16 6YD

Southampton University Hospitals NHS Trust, Southampton

ST4 6QG

Royal Stoke University Hospital, Stoke-on-Trent

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03099187 - A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease | Biotech Hunter | Biotech Hunter